MYLAN P155 (Metformin hydrochloride and pioglitazone hydrochloride 500 mg / 15 mg (base))
Pill imprint MYLAN P155 has been identified as Metformin hydrochloride and pioglitazone hydrochloride 500 mg / 15 mg (base).
Metformin/pioglitazone is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Metformin/pioglitazone 500 mg / 15 mg (base) is not subject to the Controlled Substances Act.
See also related documents.
Images for MYLAN P155 (Metformin hydrochloride and pioglitazone hydrochloride 500 mg / 15 mg (base))
More about metformin/pioglitazone
- Metformin extended-release/pioglitazone
- Pioglitazone/metformin extended-release tablets
- Metformin and pioglitazone
- More (2) »
- Pioglitazone and Metformin Tablets (FDA)
- Pioglitazone Hydrochloride/Metformin Hydrochloride (Wolters Kluwer)
Compare with other treatments for:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...